Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-infected women receiving cotrimoxazole prophylaxis: a multicenter randomized placebo-controlled trial - Wikidata - wikimedia - TriplyDB

Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-infected women receiving cotrimoxazole prophylaxis: a multicenter randomized placebo-controlled trial

Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-infected women receiving cotrimoxazole prophylaxis: a multicenter randomized placebo-controlled trial

http://www.wikidata.org/entity/Q28543154

about

Antimalarial drugs for preventing malaria during pregnancy and the risk of low birth weight: a systematic review and meta-analysis of randomized and quasi-randomized trials Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-negative women: a multicentre randomized controlled trial Economic evaluation of an alternative drug to sulfadoxine-pyrimethamine as intermittent preventive treatment of malaria in pregnancy Parasitological Clearance Rates and Drug Concentrations of a Fixed Dose Combination of Azithromycin-Chloroquine in Asymptomatic Pregnant Women with Plasmodium Falciparum Parasitemia: An Open-Label, Non-Comparative Study in Sub-Saharan Africa Scheduled Intermittent Screening with Rapid Diagnostic Tests and Treatment with Dihydroartemisinin-Piperaquine versus Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy in Malawi: An Open-Label Randomized Control Effects of HIV infection on maternal and neonatal health in southern Mozambique: A prospective cohort study after a decade of antiretroviral drugs roll out.Resisting and tolerating P. falciparum in pregnancy under different malaria transmission intensities Malaria prevention during pregnancy-is there a next step forward?Mefloquine Versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment in Pregnancy: A Joint Analysis on Efficacy and Tolerability User and Provider Acceptability of Intermittent Screening and Treatment and Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine to Prevent Malaria in Pregnancy in Western Kenya A Public Health Paradox: The Women Most Vulnerable to Malaria Are the Least Protected Infant mortality and morbidity associated with preterm and small-for-gestational-age births in Southern Mozambique: A retrospective cohort study Malaria during Pregnancy.Pharmacokinetics of mefloquine and its effect on sulfamethoxazole and trimethoprim steady-state blood levels in intermittent preventive treatment (IPTp) of pregnant HIV-infected women in Kenya.Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an op Treatment and prevention of malaria in pregnancy in the private health sector in Uganda: implications for patient safety.Malaria, malnutrition, and birthweight: A meta-analysis using individual participant data.Congenital and perinatally-acquired infections in resource-constrained settings.Prevention and control of malaria in pregnancy - new threats, new opportunities?Dosage of Sulfadoxine-Pyrimethamine and Risk of Low Birth Weight in a Cohort of Zambian Pregnant Women in a Low Malaria Prevalence Region.The Challenge of Assessing Microcephaly in the Context of the Zika Virus Epidemic.Determinants of virological failure and antiretroviral drug resistance in Mozambique.Gilding the Lily? Enhancing Antenatal Malaria Prevention in HIV-Infected Women.Multiplexing detection of IgG against Plasmodium falciparum pregnancy-specific antigens.Prenatal Iron Deficiency, Neonatal Ferritin, and Infant Cognitive Function.Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine: More Than Just an Antimalarial?Management of malaria in pregnancy.Use of trimethoprim-sulfamethoxazole during pregnancy and risk of spontaneous abortion: a nested case control study.Mefloquine for preventing malaria in pregnant women.HIV drug resistance patterns in pregnant women using next generation sequence in Mozambique.Consequences of prenatal geophagy for maternal prenatal health, risk of childhood geophagy and child psychomotor development Animal Embryotoxicity Studies of Key Non-Artemisinin Antimalarials and Use in Women in the First Trimester Reduced Nevirapine Concentrations Among HIV-Positive Women Receiving Mefloquine for Intermittent Preventive Treatment for Malaria Control During Pregnancy

P2860

Q26798114-B99EAB24-06C8-40C0-8B45-A8603AF861D9 Q28543146-5CED9551-FCF8-4C92-AD7C-4D3F96C0F72A Q28546725-67C7E487-1D2D-4706-8C75-1B08D231A29A Q28553597-BA78D76C-A552-4AD8-B7FD-10DCF97E1246 Q28554025-DBA60CA0-289D-4A4A-9E57-2B2A9F61E58A Q33757461-D08E8E8F-4E4E-408C-B239-70D1559EEB80 Q33910163-EF5D5EE1-2BBF-4816-969B-AA941066D160 Q34231478-C0F99AD2-1C49-4632-B656-CA6986DA2AD9 Q35933939-0F8EB325-4B56-4FA5-9D5B-740414772D4E Q35960893-F14A2275-98CC-49BB-8F04-8A30C6DD1813 Q36006670-54A89FE5-E14E-4B54-A441-6ADE1519851D Q36284085-A6FCB903-81D4-4843-AEFF-A247E79F0ECE Q36284603-FAB9BEC4-8171-4196-A68E-6C20250F3F73 Q36428895-08D8EFCD-1F8A-4A46-8208-DDCF728F5C82 Q36478633-9ECE4278-264E-4F22-8A36-83BA432D3355 Q36796954-B4CCEBEC-ED4C-406D-AB71-F8037989BCA4 Q38632443-1A9BE735-42B0-4F87-8F61-A2B8BA947A2F Q38904188-68FA931D-062D-4C5C-8104-20B30923DEC1 Q39038490-70223777-24A0-4088-B353-4A3F45018B98 Q39229580-BA96C31F-01EC-4521-8652-36F8B1811271 Q39375377-F6B84F08-77EA-4FA5-8FCC-5D75E0F6301C Q39414398-7C5679F8-9F5E-4491-9C96-9A95708B5B22 Q39517560-66619925-8A15-49DA-B302-380FFD103A1D Q40120062-0FEDEAC7-DB8D-4CAF-8E09-EDCAD074339F Q40414398-F257BECF-0E9F-41D1-86FA-5B55DF8F9A66 Q42330176-7499B8B2-EAFF-420E-B6DD-B2CBA5385319 Q47797899-F85F4EBD-8025-4F87-9BB6-288F001EA4C9 Q50103216-2EA4A16B-E05B-4E76-95FE-21C539AD179B Q51737259-6A3DB2C6-AC55-4180-A3EF-1BD1C2247517 Q55256755-75EE6294-A93A-4115-9BC2-0366AFA7E270 Q56354255-4B82FD15-009F-4B34-962F-D811DB427FF9 Q56428696-2FB03D78-E7A0-4E7A-88DF-58E66086B026 Q57287116-52EEB564-1FD6-4D7B-B73B-826893413759

P2860

Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-infected women receiving cotrimoxazole prophylaxis: a multicenter randomized placebo-controlled trial

http://www.wikidata.org/entity/Q28543154

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Intermittent preventive treatm ...... mized placebo-controlled trial

@ast

Intermittent preventive treatm ...... mized placebo-controlled trial

@en

Intermittent preventive treatm ...... mized placebo-controlled trial

@nl

type

label

Intermittent preventive treatm ...... mized placebo-controlled trial

@ast

Intermittent preventive treatm ...... mized placebo-controlled trial

@en

Intermittent preventive treatm ...... mized placebo-controlled trial

@nl

prefLabel

Intermittent preventive treatm ...... mized placebo-controlled trial

@ast

Intermittent preventive treatm ...... mized placebo-controlled trial

@en

Intermittent preventive treatm ...... mized placebo-controlled trial

@nl

P1433

Q28543154-92AE01E7-CF12-4BF2-8809-B05CA399FEA3

P1476

Q28543154-4C833DAC-B439-44B9-A2F1-5E1007B715FB

P2093

Q28543154-00D70F92-4CD4-4967-BC14-9DCD210CA904

Q28543154-0CEB588C-4748-4AB0-AAE4-608BA691B07D

Q28543154-354F04F1-4721-4B36-A6B4-704EC8290C20

Q28543154-5086EA9C-D049-4AF6-A6FE-A0E8DAFE30BF

Q28543154-53EF4D14-00FE-4440-9D39-AA1A7748E40F

Q28543154-59A83476-D89B-4CF8-A78C-71910A5D0218

Q28543154-6F119B5E-9972-404B-8CC2-8103FFBBE788

Q28543154-82E9A088-8DD0-49D6-AE19-A055FF3EE10D

Q28543154-85C0DFD6-54E5-4179-8DE7-B79D70198D58

Q28543154-8C854AC1-D991-488C-845F-03E499B5BDBE

P2860

Q28543154-039AF7EA-899B-48C6-9C26-71DAE6DFB3BD

Q28543154-03A73F67-0C39-48BA-A543-7D88DE813FC8

Q28543154-08DBCC90-3DF5-4ED1-A15F-AEE56469118A

Q28543154-08E7E88B-84EF-4A2B-9F6F-A202BD35580C

Q28543154-0E1D987D-AEA7-4B95-8E13-7D8E30C0B724

Q28543154-0F3DBAC8-3BFE-48E8-BF03-17DAFA4808B1

Q28543154-0FD3BDAD-CF23-458B-8052-6B0281158522

Q28543154-18FC404B-72D2-4F31-B21C-8FEC4B70F6AB

Q28543154-1B4E3446-311E-4CFE-8C6C-14787A1D94F2

Q28543154-1B673778-1DEE-474F-A756-1238BB11B4F7

P304

Q28543154-11E1FD9D-85F2-49A6-B454-A03C6DA5B6F7

P31

Q28543154-DAF1A504-8B81-4720-B16B-44770588DD9C

P3181

Q28543154-F45A2485-57D4-42FA-8BB0-78DDD598B76A

P356

Q28543154-1D1AC56C-A448-45D5-A77B-B1382EF4E994

P407

Q28543154-8B9B88BB-9CA2-453E-82BA-5F6C48B37B3A

P433

Q28543154-70D37D33-A703-4F36-B055-430B7993017A

P478

Q28543154-E16CDA43-84E7-44DD-856F-F71A35C56BD8

P50

Q28543154-15084F49-61D8-4006-9141-92882AF09B17

Q28543154-70D3E41D-2198-4105-93CA-D30471EB833E

Q28543154-9C1861D9-E38E-4FF4-A38F-97F10E7DA18D

Q28543154-A10E326E-8B33-4BD2-8B6D-10E953549CAD

Q28543154-CF2D0F93-6B2C-461A-A26C-799C4B3957CF

P577

Q28543154-EC888EB2-EB74-45DE-AE28-6B8D112EABD8

P5875

Q28543154-FB3C6D47-8366-48E1-9484-61A5500F2EA0

P698

Q28543154-08179454-21C3-4C9A-A165-194E018E242B

P921

Q28543154-057F82F7-CE8F-4EEE-B47F-98E0ECB52E99

Q28543154-2181E8AC-BD23-4E85-9049-153C26AD47AF

Q28543154-40EB107D-B63C-4EB0-A45D-69E01A5381D9

Q28543154-BF36273F-DC18-498B-ABB7-3103894C80F8

Q28543154-DB1E2BCF-E72A-4829-BF85-E5AB98845DD0

P932

Q28543154-41F9B2D6-063F-44D1-99B7-12E84FFC7B37

P3181

P356

JOURNAL.PMED.1001735

P1433

P1476

Intermittent preventive treatm ...... mized placebo-controlled trial

@en

P2093

Abdunoor M Kabanywanyi

http://www.w3.org/2001/XMLSchema#string

Abraham Katana

http://www.w3.org/2001/XMLSchema#string

Alfredo Mayor

http://www.w3.org/2001/XMLSchema#string

Anifa Vala

http://www.w3.org/2001/XMLSchema#string

Arsenio Nhacolo

http://www.w3.org/2001/XMLSchema#string

Clara Menéndez

http://www.w3.org/2001/XMLSchema#string

Esperança Sevene

http://www.w3.org/2001/XMLSchema#string

Eusebio Macete

http://www.w3.org/2001/XMLSchema#string

Golbahar Pahlavan

http://www.w3.org/2001/XMLSchema#string

Helder Bulo

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnosis of Plasmodium falciparum Malaria at Delivery: Comparison of Blood Film Preparation Methods and of Blood Films with Histology

The position of mefloquine as a 21st century malaria chemoprophylaxis

Mefloquine safety and tolerability in pregnancy: a systematic literature review

Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach

Pregnancy and susceptibility to infectious diseases

Pharmacokinetic interaction between mefloquine and ritonavir in healthy volunteers

Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-negative women: a multicentre randomized controlled trial

A modified poisson regression approach to prospective studies with binary data

Effect of HIV infection on pregnancy-related mortality in sub-Saharan Africa: secondary analyses of pooled community-based data from the network for Analysing Longitudinal Population-based HIV/AIDS data on Africa (ALPHA).

An autopsy study of maternal mortality in Mozambique: the contribution of infectious diseases

P304

e1001735

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1903273

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PMED.1001735

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Laurence Slutsker

P577

2014-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266027010

http://www.w3.org/2001/XMLSchema#string

P698

25247995

http://www.w3.org/2001/XMLSchema#string

P921

multicenter trial

pregnancy-associated malaria

P932

4172537

http://www.w3.org/2001/XMLSchema#string